Related Experiment Video
Updated: Jun 11, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
Ester Lara1, Vincenzo Calvanese, Covadonga Huidobro
1Department of Immunology and Oncology, National Center for Biotechnology, CNB-CSIC, Cantoblanco, Madrid E-28049, Spain.
Background:
Wnt factors control cell differentiation through semi-independent molecular cascades known as the beta-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood.
Results:
Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic.
Conclusions:
Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour.
Insights
Aberrant methylation of ROR2, a non-canonical Wnt pathway receptor, is frequent in colon cancer. Its loss promotes tumors by impacting canonical Wnt signaling, revealing a crucial link between Wnt pathways in cancer.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Wnt signaling pathways, canonical (beta-catenin-dependent) and non-canonical (beta-catenin-independent), regulate cell differentiation.
- Alterations in canonical Wnt signaling are key drivers of colon cancer.
- The role of non-canonical Wnt pathways in tumorigenesis is not well understood.
Purpose of the Study:
- Investigate the role of the non-canonical Wnt receptor ROR2 in colon cancer.
- Determine the mechanisms of ROR2 regulation in colon cancer.
- Explore the interplay between canonical and non-canonical Wnt pathways in colon cancer.
Main Methods:
- Analysis of ROR2 promoter methylation in colon cancer cell lines and primary tumors.
- Restoration of ROR2 activity in colon cancer cells.
- Assessment of Wnt pathway activation following ROR2 restoration.
Main Results:
- ROR2 is frequently repressed by promoter hypermethylation in colon cancer.
- Restoring ROR2 activity in cancer cells impacts canonical Wnt signaling.
- Epigenetic silencing of ROR2 is pro-tumorigenic in colon cancer.
Conclusions:
- Epigenetic repression of ROR2 is a significant event in colon cancer.
- ROR2's function in colon cancer involves canonical Wnt signaling.
- This study highlights the interconnection between canonical and non-canonical Wnt pathways in colon cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...